Alicia and Jon Langenhop's three children were each diagnosed with a rare disorder. A clinical trial was "a no-brainer." ...

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including ...

DelveInsight’s Renal Cell Carcinoma Pipeline report depicts a robust space with 30+ active players working to develop 30+ ...

Pancreatic cancer remains one of the most formidable oncological challenges of our time. Known for its late detection and ...

CHINO HILLS, CA / ACCESS Newswire / May 2, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, proudly announces ...

The world of oncology is evolving rapidly, with breakthrough technologies transforming the way cancer is treated and managed.

An expert discusses how treatment selection in blastic plasmacytoid dendritic cell neoplasm (BPDCN) involves balancing ...

An expert discusses how effective blastic plasmacytoid dendritic cell neoplasm (BPDCN) management requires early central ...

In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...

Phase I trial demonstrates lasting responses and encouraging safety profile in two aggressive thyroid cancer subtypes, suggesting further progress for CAR T cell therapy in solid tumors One patient ...

A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make ...